Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $16.5 million.

  • Rapid Micro Biosystems' Total Current Liabilities rose 393.84% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 393.84%. This contributed to the annual value of $17.6 million for FY2024, which is 748.45% down from last year.
  • Rapid Micro Biosystems' Total Current Liabilities amounted to $16.5 million in Q3 2025, which was up 393.84% from $16.4 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Total Current Liabilities high stood at $19.0 million for Q4 2022, and its period low was $12.8 million during Q2 2022.
  • Its 5-year average for Total Current Liabilities is $16.1 million, with a median of $16.0 million in 2021.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Total Current Liabilities soared by 1686.07% in 2021, and later crashed by 2033.74% in 2022.
  • Over the past 5 years, Rapid Micro Biosystems' Total Current Liabilities (Quarter) stood at $18.2 million in 2021, then increased by 4.87% to $19.0 million in 2022, then dropped by 0.34% to $19.0 million in 2023, then fell by 7.48% to $17.6 million in 2024, then fell by 5.8% to $16.5 million in 2025.
  • Its last three reported values are $16.5 million in Q3 2025, $16.4 million for Q2 2025, and $15.0 million during Q1 2025.